130 related articles for article (PubMed ID: 31891684)
1. Tenovin-6 induces the SIRT-independent cell growth suppression and blocks autophagy flux in canine hemangiosarcoma cell lines.
Igase M; Fujiki N; Shibutani S; Sakai H; Noguchi S; Nemoto Y; Mizuno T
Exp Cell Res; 2020 Mar; 388(1):111810. PubMed ID: 31891684
[TBL] [Abstract][Full Text] [Related]
2. Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy.
Yuan H; He M; Cheng F; Bai R; da Silva SR; Aguiar RC; Gao SJ
Oncotarget; 2017 Feb; 8(9):14912-14924. PubMed ID: 28118604
[TBL] [Abstract][Full Text] [Related]
3. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
4. Tenovin-6 impairs autophagy by inhibiting autophagic flux.
Yuan H; Tan B; Gao SJ
Cell Death Dis; 2017 Feb; 8(2):e2608. PubMed ID: 28182004
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-related apoptosis-inducing ligand induces apoptosis in canine hemangiosarcoma cells in vitro.
Goto M; Owaki K; Hirata A; Yanai T; Sakai H
Vet Comp Oncol; 2019 Sep; 17(3):285-297. PubMed ID: 30767429
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
Andersen NJ; Nickoloff BJ; Dykema KJ; Boguslawski EA; Krivochenitser RI; Froman RE; Dawes MJ; Baker LH; Thomas DG; Kamstock DA; Kitchell BE; Furge KA; Duesbery NS
Mol Cancer Ther; 2013 Sep; 12(9):1701-14. PubMed ID: 23804705
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
[TBL] [Abstract][Full Text] [Related]
8. Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner.
McCarthy AR; Sachweh MC; Higgins M; Campbell J; Drummond CJ; van Leeuwen IM; Pirrie L; Ladds MJ; Westwood NJ; Laín S
Mol Cancer Ther; 2013 Apr; 12(4):352-60. PubMed ID: 23322738
[TBL] [Abstract][Full Text] [Related]
9. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
[TBL] [Abstract][Full Text] [Related]
10. Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib.
Ladds MJGW; Pastor-Fernández A; Popova G; van Leeuwen IMM; Eng KE; Drummond CJ; Johansson L; Svensson R; Westwood NJ; McCarthy AR; Tholander F; Popa M; Lane DP; McCormack E; McInerney GM; Bhatia R; Laín S
PLoS One; 2018; 13(4):e0195956. PubMed ID: 29684045
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6.
MacCallum SF; Groves MJ; James J; Murray K; Appleyard V; Prescott AR; Drbal AA; Nicolaou A; Cunningham J; Haydock S; Ganley IG; Westwood NJ; Coates PJ; Lain S; Tauro S
Sci Rep; 2013; 3():1275. PubMed ID: 23429453
[TBL] [Abstract][Full Text] [Related]
12. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.
Morita A; Aoshima K; Gulay KCM; Onishi S; Shibata Y; Yasui H; Kobayashi A; Kimura T
Res Vet Sci; 2019 Dec; 127():1-10. PubMed ID: 31648115
[TBL] [Abstract][Full Text] [Related]
13. Generation of a novel model of primary human cell senescence through Tenovin-6 mediated inhibition of sirtuins.
Walters HE; Cox LS
Biogerontology; 2019 Jun; 20(3):303-319. PubMed ID: 30666570
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.
Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T
Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989
[TBL] [Abstract][Full Text] [Related]
15. Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.
Adachi M; Hoshino Y; Izumi Y; Sakai H; Takagi S
Can J Vet Res; 2016 Jul; 80(3):209-16. PubMed ID: 27408334
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine.
Ke X; Qin Q; Deng T; Liao Y; Gao SJ
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033497
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
Pyuen AA; Meuten T; Rose BJ; Thamm DH
PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
[TBL] [Abstract][Full Text] [Related]
20. Tenovin-1 inhibited dengue virus replication through SIRT2.
Wan Y; Wu W; Zhang J; Li L; Wan Y; Tang X; Chen X; Liu S; Yao X
Eur J Pharmacol; 2021 Sep; 907():174264. PubMed ID: 34147476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
